N@N

Exelixis Announces May 3rd Webcast of Its First Quarter 2011 Financial Results Conference Call

_{//health-fitness.news-articles.net/content/2011/ .. rter-2011-financial-results-conference-call.html}
^{Published in Health and Fitness on Thursday, April 21st 2011 at 13:20 GMT by Market Wire}  

SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (NASDAQ: EXEL) will release its first quarter 2011 financial results on Tuesday, May 3, 2011, after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT. During the webcast, Exelixis management will discuss the companya™s financial results, 2011 financial guidance, corporate strategy, and provide a general business update. The webcast may be accessed in the Event Calendar page under Investors and Media at [ www.exelixis.com ].

An archived replay of the webcast will be available on the Event Calendar page under Investors and Media at [ www.exelixis.com ] and via phone until 11:59 p.m. EDT on June 3, 2011. Access numbers for the phone replay are: 888-286-8010 (domestic) and 617-801-6888 (international); the passcode is 67033533.

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the companya™s web site at [ www.exelixis.com ].